Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $27,023 - $44,484
-267 Reduced 0.78%
34,027 $4.04 Million
Q1 2024

Jun 10, 2024

SELL
$85.37 - $115.44 $3.24 Million - $4.38 Million
-37,907 Reduced 52.5%
34,294 $3.65 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $3.99 Million - $5.99 Million
57,339 Added 385.81%
72,201 $7.18 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.43 Million - $1.88 Million
14,862 New
14,862 $1.54 Million
Q1 2023

May 08, 2023

BUY
$135.66 - $197.02 $102,423 - $148,750
755 Added 7.29%
11,107 $1.71 Million
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $1.23 Million - $2.17 Million
10,352 New
10,352 $1.86 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hamilton Wealth, LLC Portfolio

Follow Hamilton Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Wealth, LLC with notifications on news.